NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 220 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $463,445 | +160.6% | 36,607 | -1.6% | 0.00% | – |
| Q1 2024 | $177,831 | +29.4% | 37,203 | +29.9% | 0.00% | – |
| Q4 2023 | $137,438 | -9.7% | 28,633 | +36.2% | 0.00% | – |
| Q3 2023 | $152,214 | +0.2% | 21,024 | +2.8% | 0.00% | – |
| Q2 2023 | $151,952 | -59.9% | 20,451 | +177.7% | 0.00% | -100.0% |
| Q2 2022 | $379,000 | -46.1% | 7,365 | -22.9% | 0.00% | -50.0% |
| Q1 2022 | $703,000 | -60.8% | 9,548 | -23.9% | 0.00% | -50.0% |
| Q4 2021 | $1,795,000 | -51.0% | 12,545 | -29.0% | 0.00% | -60.0% |
| Q3 2021 | $3,664,000 | +9.4% | 17,676 | +12.0% | 0.01% | 0.0% |
| Q2 2021 | $3,350,000 | -30.5% | 15,779 | -40.7% | 0.01% | -33.3% |
| Q1 2021 | $4,820,000 | +76.2% | 26,587 | +8.4% | 0.02% | +50.0% |
| Q4 2020 | $2,736,000 | +196.1% | 24,537 | +187.6% | 0.01% | +150.0% |
| Q3 2020 | $924,000 | +40.2% | 8,531 | +7.8% | 0.00% | 0.0% |
| Q2 2020 | $659,000 | – | 7,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |